Literature DB >> 6480952

Herpes zoster and occult malignancy.

M A Fueyo, D P Lookingbill.   

Abstract

Herpes zoster and malignancy have both been associated with conditions of immune suppression. It has been well documented that herpes zoster occurs more frequently in patients with a previously diagnosed malignancy, especially lymphoma. To determine whether there is an increased frequency of malignancy subsequent to the diagnosis of herpes zoster, we studied fifty outpatients with herpes zoster and compared them with fifty control patients with psoriasis. In a follow-up period ranging from 24 to 68 months, one individual in the herpes zoster group developed a subsequent malignancy, in comparison to none in the control population and to 1.5 cancer cases expected in the general population. These results support the view that herpes zoster is not a marker for an occult malignancy.

Entities:  

Mesh:

Year:  1984        PMID: 6480952     DOI: 10.1016/s0190-9622(84)70195-2

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  10 in total

1.  Is herpes zoster a marker for occult or subsequent malignancy?

Authors:  Frank Buntinx; Richard Wachana; Stefaan Bartholomeeusen; Kathleen Sweldens; Helena Geys
Journal:  Br J Gen Pract       Date:  2005-02       Impact factor: 5.386

2.  The incidence of herpes zoster in a United States administrative database.

Authors:  Ralph P Insinga; Robbin F Itzler; James M Pellissier; Patricia Saddier; Alexander A Nikas
Journal:  J Gen Intern Med       Date:  2005-08       Impact factor: 5.128

3.  The Association between Herpes Zoster and Increased Cancer Risk: A Nationwide Population-Based Matched Control Study.

Authors:  Ji-Hoon Sim; Hyun-Seok Cho; Young-Do Kim; Juhan Mun; Sung-Bae Kim; Jong-Hyuk Lee; Jeong-Gil Leem
Journal:  Curr Oncol       Date:  2021-07-17       Impact factor: 3.677

4.  Herpes zoster: a clinical study in 205 patients.

Authors:  E N Abdul Latheef; K Pavithran
Journal:  Indian J Dermatol       Date:  2011 Sep-Oct       Impact factor: 1.494

5.  Association between recent herpes zoster but not herpes simplex infection and subsequent risk of malignancy in women: a retrospective cohort study.

Authors:  F Buntinx; S Bartholomeeusen; A Belmans; C Mathei; G Opdenakker; K Sweldens; C Truyers; M Van Ranst
Journal:  Epidemiol Infect       Date:  2013-08-02       Impact factor: 4.434

6.  Herpes zoster and subsequent risk of cancer: a population-based study.

Authors:  Hui-Fen Chiu; Brian K Chen; Chun-Yuh Yang
Journal:  J Epidemiol       Date:  2013-04-01       Impact factor: 3.211

7.  Increased risk of lymphoid malignancy in patients with herpes zoster: a longitudinal follow-up study using a national cohort.

Authors:  Hyo Geun Choi; James L Zehnder; Young Kyung Lee; Hyun Lim; Miyoung Kim
Journal:  BMC Cancer       Date:  2019-11-27       Impact factor: 4.430

8.  The risk of a subsequent cancer diagnosis after herpes zoster infection: primary care database study.

Authors:  S J Cotton; J Belcher; P Rose; S K Jagadeesan; R D Neal
Journal:  Br J Cancer       Date:  2013-01-29       Impact factor: 7.640

9.  The risk and prognosis of cancer after hospitalisation for herpes zoster: a population-based follow-up study.

Authors:  H T Sørensen; J H Olsen; P Jepsen; S P Johnsen; H C Schønheyder; L Mellemkjaer
Journal:  Br J Cancer       Date:  2004-10-04       Impact factor: 7.640

10.  Herpes zoster as a marker of underlying malignancy.

Authors:  Karl Iglar; Alexander Kopp; Richard H Glazier
Journal:  Open Med       Date:  2013-06-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.